Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000931 · ClinicalTrials.gov registry record · Phase 3
HIV Prevention Counseling for Men Who Have Sex With Men
A Phase 3 study, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- Phase 3
- Development phase
- 4,350
- Enrollment target
NCT00000931: Completed Phase 3 study, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
NCT00000931 is a Phase 3 study that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 4,350 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (463% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00000931, a Phase 3 study, has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 4,350 participants
- Enrollment target
Study Summary
The purpose of this study is to see if a behavioral intervention, a special kind of counseling, can reduce the risk of HIV infection in men who have sex with men. The behavioral intervention will be compared to the standard risk reduction counseling that is given before and after getting an HIV test. In standard pre- and post-test counseling, everyone is told the same things about how to prevent HIV. The behavioral intervention used in this study is designed to help each individual prevent HIV according to his specific problems and needs.
Interventions
- BEHAVIORAL Behavioral intervention
- BEHAVIORAL Risk-reduction counseling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,350 participants |
| Phase | Phase 3 |
What the finished NCT00000931 record still lists
NCT00000931 is an interventional study that assigns participants to a tested intervention. Its 4,350 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (463% higher).
The record links to 0 conditions, and to 2 interventions - of which Behavioral intervention is the first listed.
NCT00000931 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00000931 about?
NCT00000931 is a clinical study titled "HIV Prevention Counseling for Men Who Have Sex With Men". The purpose of this study is to see if a behavioral intervention, a special kind of counseling, can reduce the risk of HIV infection in men who have sex with men. The behavioral intervention will be compared to the standard risk reduction counseling that is given before and after getting an HIV test...
What is the current status of trial NCT00000931?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 4,350 participants.
What interventions are being tested in trial NCT00000931?
The interventions under investigation include: Behavioral intervention (BEHAVIORAL), Risk-reduction counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT00000931?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00000931's enrollment target sits among peer trials
4,350 57th of 2000 higher than 1,944 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05910567 · 4,346 participants · NA
A Research Study of Abdominal Ultrasound (FAST) in Children With Blunt Torso Trauma
- NCT07044297 · 4,390 participants · Phase 3
A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
- NCT02660645 · 4,400 participants
Blue Light Cystoscopy With Cysview® Registry
- NCT05774951 · 4,300 participants · Phase 3
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy